The latest closing stock price for Aspire Biopharma Holdings as of May 08, 2025 is 0.34.
An investor who bought $1,000 worth of Aspire Biopharma Holdings stock at the IPO in 2022 would have $-966 today, roughly -1 times their original investment - a -67.74% compound annual growth rate over 3 years.
The all-time high Aspire Biopharma Holdings stock closing price was 14.01 on February 11, 2025.
The Aspire Biopharma Holdings 52-week high stock price is 15.80, which is 4547.1% above the current share price.
The Aspire Biopharma Holdings 52-week low stock price is 0.32, which is 5.9% below the current share price.
The average Aspire Biopharma Holdings stock price for the last 52 weeks is 8.28.
An investor who bought $1,000 worth of Aspire Biopharma Holdings stock at the IPO in 2022 would have $-966 today, roughly -1 times their original investment - a -67.74% compound annual growth rate over 3 years.
The all-time high Aspire Biopharma Holdings stock closing price was 14.01 on February 11, 2025.
The Aspire Biopharma Holdings 52-week high stock price is 15.80, which is 4547.1% above the current share price.
The Aspire Biopharma Holdings 52-week low stock price is 0.32, which is 5.9% below the current share price.
The average Aspire Biopharma Holdings stock price for the last 52 weeks is 8.28.